mutant&#32

2 trials

Sponsors

Zhongshan Hospital, Fudan University, Beijing Chest Hospital

Conditions

colorectal cancernon-small cell lung cancer (NSCLC)

Early Phase 1

Establishment and validation of therapeutic effect prediction model of first line treatment of bevacizumab combined with mFOLFOX6 in Ras mutant colorectal cancer patients with liver metastasis

Active, not recruitingChiCTR2000036551

Zhongshan Hospital, Fudan Universitycolorectal cancer

Start: 2020-09-01Updated: 2020-09-14

Unknown Phase

Gene Sequencer Clinical Trials

Active, not recruitingChiCTR2100053804

Beijing Chest Hospitalnon-small cell lung cancer (NSCLC)

Start: 2021-11-29Updated: 2022-10-24